SUMMARY Growth was assessed in 38 prepubertal children with chronic renal failure for a mean (range) of 2*3 (1-4) years. At first clinic visit their mean (range) glomerular filtration rate was 17 (7-35) ml/min/1-73 m2, their mean (range) age was 3X4 (0-2-9X1) years, and 23 (61%) were greater than two standard deviations below the mean for height. After (1) Chronological age at first clinic visit (years). The children were divided according to presentation before (group 1, n= 16) or after (group 2, n=22) age 2 years. The mean (range) age of group 1 at presentation was 1-0 (0.2-1.8) and of group 2 was 5 2 (2.5-9-1) years.
SUMMARY Growth was assessed in 38 prepubertal children with chronic renal failure for a mean (range) of 2*3 (1-4) years. At first clinic visit their mean (range) glomerular filtration rate was 17 (7-35) ml/min/1-73 m2, their mean (range) age was 3X4 (0-2-9X1) years, and 23 (61%) were greater than two standard deviations below the mean for height. After intensive medical management of their chronic renal failure, half of the children who presented before 2 years of age showed appreciable catch up growth. Only a slow improvement in growth occurred in most children presenting over 2 years of age. At final assessment, the mean (range) glomerular filtration rate was 15 (6-42) ml/min/1 73 and 20(53%) were greater than two standard deviations below the mean for height. There was no correlation between glomerular filtration rate and growth. There remained a group of children who continued to grow poorly. Many of these were of low birth weight, and had dysplastic kidneys.
Growth retardation is a major problem for children with chronic renal failure.'-4 In 1983 we set up a clinic for children with severe chronic renal failure to enable optimal management of diet, electrolyte and acid-base balance, and bone disease. 5 We have analysed the effects of intensive medical management on the growth and renal function of prepubertal children attending the clinic.
Patients and methods All children aged less than 10 years who were prepubertal and who had attended Guy's Hospital chronic renal failure clinic for at least a year were included in the study (32 boys, six girls). The children attended the clinic at least once every three months, but most attended once every four weeks or more frequently. Most (-0-5, -1.4 to 0). By the end of the second year, 11 children had improved their rate of growth (0-9, 04 to 2-1), whereas only three had failed to do so (-0-6, -0-8 to -0-4). Continuing improvement in growth occurred in five of the seven children after three years, and three of the five children after four years. Growth over the first two years was better in the children of birth weight >10th centile (1-0, 0-l to 1-6), than in those of birth weight <10th centile (0-2, -0-8 to 1-1), but this did not reach significance. All three of the children whose growth was declining after two years were of birth weight <10th centile, and had dysplasia with or without reflux. Six of the 10 children who were tube fed showed an improvement in their rate of growth (patients 3, 5, 6, 9, 10, 11). In two (patients 3 and 5) a dramatic effect was seen (fig 2) . Previous use of aluminium hydroxide did not affect growth, nor did the number of clinic visits per year. There was no relation between the concentrations of plasma sodium, bicarbonate, urea, and albumin or the haemoglobin and growth. GROUP 2 Fig 3 shows the individual longitudinal height data for the 22 children who presented to the clinic after the age of 2 years. Eleven were greater than 2 SD below the mean at first clinic visit, and seven of these were greater than -3 SD. Changes in rates of growth were less dramatic in this group. Thirteen children showed an improvement in Ht SDS over the first year (mean A Ht SDS 0-2, range, 0-1 to 1-0); in two Ht SDS remained unchanged; in seven it deteriorated (-0-2, -0-1 to -0-5). By the end of the second year, eight of the 12 children had improved their Ht SDS (0.4, 0-2 to 1-0), one remained unchanged, and two had shown a deterioration (-0.3, -0-1 to -0-4). Continuing slow improvement in growth occurred in five of the eight children after three years. Over the fourth year, Ht SDS of the five patients remained unchanged. Four of the eight children with dysplasia with or without reflux were among the seven children greater than -3 SD below the mean for height at presentation.
There was no correlation between glomerular filtration rate and rate of growth in either group.
Discussion
The beneficial effects of early transplantation on growth," 12 and the recent availability of growth hormone as a therapeutic possibility, make it particularly important that the growth patterns of children with chronic renal failure should be studied. Sixty percent of our children were already below the third centile for height when they were first seen in our clinic. Other centres have reported similar findings.2 3 The rapid growth and high energy requirements during the first two years of life make this the time when most of the adverse effect on height occurs, and fall in Ht SDS has been reported to be as high as 0-6 SD per month.2 3 remains a potential for catch up growth, but it is still unknown why children with chronic renal failure do not catch up to their genetic potential. We were unable to find any correlation between the glomerular filtration rate and the rate of growth, in agreement with other reports. [2] [3] [4] In conclusion, many children with chronic renal failure are short by the time they are seen by a paediatric nephrologist. Strict attention to diet, electrolyte and acid-base balance, and the prevention of osteodystrophy may result in dramatic catch up growth in some infants who are treated during the first two years of life. If treatment is delayed until after two years of age, a slow improvement in growth occurs in most children. There remains a group of children, however, whose growth is resistant to theoretically optimal management. Many of these are of low birth weight and have dysplasia with or without reflux. These children may benefit from an alternative approach such as transplantation before end stage renal failure is reached, or growth hormone treatment in supraphysiological doses.
